Fri, Apr 25, 2014, 12:40 AM EDT - U.S. Markets open in 8 hrs 50 mins


% | $
Quotes you view appear here for quick access.

Staples, Inc. Message Board

gswkool 65 posts  |  Last Activity: Apr 23, 2014 4:59 PM Member since: Jan 2, 2012
  • to grow into its market cap. I used to own shares and took a profit. The rollout of its telepresence robot will take some time to make significant difference to the company. Will they actually make money on it from the get-go or do they need to be able to mass produce to bring costs down and profits up? The company does have nice balance sheet with ample cash. I would look at it again when it falls below $30....

  • Reply to

    "can't talk about it"

    by gswkool Apr 19, 2014 4:47 PM
    gswkool gswkool Apr 23, 2014 9:21 AM Flag

    I haven't sold any shares, Mick. In fact, bought some more on the dip. Sticking my neck out blindly. I see from today that the CEO will be talking about Tethadur at an upcoming conference. Must mean they are moving the needle on developments there. I'm holding and will wait until outcome of Lluvien PDUFA before making any decisions on my holdings.....GLTA

  • Reply to

    Boycott UPS!

    by aladinwiz Apr 3, 2014 4:17 PM
    gswkool gswkool Apr 20, 2014 11:50 AM Flag

    In boycotting UPS you are actually hurting the same workers that you are trying to support through your actions. Without packages to deliver, those same workers will be out of a good paying job with health benefits. If you asked those same workers what actions you should and should not take to support them, - you may be surprised by their response...

  • I went back to February presentation and on slide 33 is latanoprost along with other pipeline activity. That is only slide it's mentioned. CEO mentions 8% ownership by Pfizer, who is their partner on latanoprost. Then I hear him say "can't talk about it". I guess they have confidentiality agreement, - this partnership goes back some time, -I'm wondering and hoping that some news will come out that will catch us off guard in a postiive way. We hear about LLuvien, Medidur, even Tethadur which is preclinical. What about poor latanoprost? I believe the PH I/II collab goes back to June of 2011 - I'm annoyed...

  • Reply to

    What's wrong with this picture

    by billygbillyg Mar 28, 2014 4:11 PM
    gswkool gswkool Mar 28, 2014 4:55 PM Flag

    It's certainly a momentum market -and with momentum markets the connection between price and value can become distorted -in both directions.

  • selling all their biotechs, - sure there are some that are overpriced, - but certainly not all biotechs. Certainly not this one. I'm happy for the buying opportunity - picked up some more PSDV shares today, as well as shares in a few others that got unfairly punished. This is a good environment for biotechs -low interest rates still, and pharmas with loads of cash and pipelines to fill out - that's why the rally in biotech space in first place. Once things have calmed down and weak hands are shaken out, I expect things to go back to focus on individual stocks and individual events that drive them....GLTA

  • Reply to

    These lawyers have no case

    by adrianthefrog Mar 28, 2014 12:47 PM
    gswkool gswkool Mar 28, 2014 12:54 PM Flag

    If GERN does not get a "release" on FDA hold, there will be nothing left for lawyers to sue. If GERN does get to resume trials, the stock will recover and lawyers' case will be weakened. Typically, these legal proceeedings drag out for years anyway, so if resumption of trials comes there will be plenty of gains here. Lawyers will be a minor nuisance...

  • Reply to

    is this newsworthy?

    by njkllkj Mar 5, 2014 4:53 PM
    gswkool gswkool Mar 28, 2014 10:37 AM Flag

    the same way i feel about the rest of my biotech holdings -which got hit hard over the last week or so. seems some big players missed the run in biotech and wanted to take it down some pegs...and were successful... i didn't give them any of my shares -I'm an investor and not a day trader. as long as the story remains intact and interest rates remain low, i'm holding....GLTA

  • Reply to

    It's Time!

    by blackmarango Mar 27, 2014 10:56 AM
    gswkool gswkool Mar 28, 2014 10:16 AM Flag

    I happened to be watching Stossel on TV last night and he was bashing the FDA. He was stating how many deaths they caused by slow drug approval process. His feeling was that we own our bodies -if we are dying who wouldn't want to try everything, approved or not? What gives FDA right to tell us what we can and what we can't put in our bodies? Should gov't bureaucrats have power of life and death over its citizens? There was a political group on the show that was pushing some legislation which would allow people who were dying to try drugs which were not approvedIt was an interesting discussion -anyhow, -there are activists for your cause out there already if you want to link up with them....GLTA

  • We can buy it cheaper than RA! Market is in pullback mode -especially biotech. I'm waiting for things to stabilize before buying again, - I'm viewing the pullback as an opportunity....

  • gswkool gswkool Mar 27, 2014 11:15 AM Flag

    do you have an "in"? do you know if the drug will ultimately be approved?

  • what a rational market ...not. Alimera is up at it possible that fda will approve shortly after acceptance or do they have to wait for pdufa date? fda has handled this whole approval process with lluvien a bit strangely....

  • Reply to


    by gswkool Mar 25, 2014 2:46 PM
    gswkool gswkool Mar 27, 2014 10:57 AM Flag

    I kinda compare what Walmart did to local businesses off-web when it moves into town - to what Amazon does to online competitors when it moves into their drives them to a trade maybe it will bounce back some -but long term I don't hold out much hope...Amazon is like the "borg" of online retail {if your a star trek fan}....anyhow...glta

  • more dilution coming....stock will be worth squat by the time they get through diluting...where is the increase in value all the b#$%shi$$%ers on the board said will happen after the merger? Market is valuing stock appropriately. It's still a tiny tot -soon to be on penny sheets...there are plenty of good stem cell companies to invest in -gotta wait though until after the biotech bloodbath that's going on right now...

  • Reply to

    $2.81 2015 earnings estimate yahoo stat

    by gswkool Mar 25, 2014 12:49 PM
    gswkool gswkool Mar 26, 2014 3:08 PM Flag

    I remember when generic Lovenox rolled out and they were profitable for a time. Then the competition came. Now they are reporting more losses, although their pipeline has expanded. I owned the stock previously and took profits thankfully. I think this type of business model is good for a trade -not sure about a long term buy. Of course, it could get acquired. I will wait for the biotech carnage to end and hopefully make a purchase at a lower price. It's really hard to put a value on this company ...

  • Reply to


    by gswkool Mar 25, 2014 2:46 PM
    gswkool gswkool Mar 26, 2014 2:59 PM Flag

    that's not a space I want to be in -competing on razor thin margins - you pointed that out and it's a good point. I always ask myself what is proprietary about the business or does it have a huge mote. AMZN has such huge scale and is so efficient -difficult to compete with. It's easy to get attached to your stocks -sometimes it's hard to let go. Anyhow, I wish you good luck..I hope your investment in SPLS works out for you...

  • Reply to


    by gswkool Mar 25, 2014 2:46 PM
    gswkool gswkool Mar 26, 2014 10:49 AM Flag

    it's margins are shrinking - esp as they shift to online sales they will be competing with likes of Amazon - look at the projected SPLS earnings estimates - they are being lowered and may continue to be. Amazon puts its earnings back into continual investment in the business. They are in continual growth mode -I don't own Amazon stock but I would certainly choose them over SPLS -no contest there...

  • Perhaps they can get the FDA to meet them at McDonalds if they offer to buy them Happy Meals....

  • Reply to


    by gswkool Mar 25, 2014 2:46 PM
    gswkool gswkool Mar 26, 2014 10:09 AM Flag

    if we were back in 1990 I would say, yeah, go for it - unfortunately, this company is growing in the opposite direction i.e. shrinking. What is cheap? When they put up a "going out of business" sign will that be cheap enough? Their business model is no longer relevant so they have to transform -but it could be too late. they will bleed more with store reductions and layoffs and shrinking margins...and don't count on the dividend -it can easily be cut.....

  • Reply to

    No Respect

    by mickmack50 Mar 25, 2014 3:02 PM
    gswkool gswkool Mar 25, 2014 7:22 PM Flag

    No worries, be happy...... biotech getting manipulation by those unhappy #$%^ who missed the run up ... story hasn't changed here, -it's a 2nd half stock. If it doesn't move in 2nd half of year then I will be very disappointed...not before then.....hang in there, -

12.105+0.195(+1.64%)Apr 24 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Lam Research Corporation
NasdaqGSThu, Apr 24, 2014 4:00 PM EDT
Apple Inc.
NasdaqGSThu, Apr 24, 2014 4:00 PM EDT